Back to
Qube Research & Technologies Ltd
PGEN
Showing 0 of 9 quarters
Position history for
Qube Research & Technologies Ltd's holdings in Precigen, Inc.
No. Qube Research & Technologies exited its PGEN (Precigen) position in Q1 2023. Its Q4 2022 13F listed 11,532 shares worth $17,529. Qube Research & Technologies first reported PGEN in Q1 2021 and held it in 7 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.